NEW YORK & LONDON--(BUSINESS WIRE)--Paige, a global leader in AI-based diagnostic software in pathology, today announced that the Company, Oxford University and National Health Service (NHS) regional ...
Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
To the investigator and clinician, prostate-specific antigen (PSA) level is a seemingly perfect outcome measure because it is easily assessable, quantitative, reproducible, and inexpensive. Whether ...
The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are ...
MRI reports and biopsy pathology reports were extracted from a cohort of 1,360,866 patients with PCa in the VA Cancer Registry System or the VA Corporate Data Warehouse, with 155,570 patients having ...
Sarah Leverett, Vice President of Marketing at Clarius, highlights the time-saving potential of AI for physicians facing high demand: "95% of clinicians we recently surveyed believe AI-powered ...
To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results